• Username (E-mail)
  • Password
Dow 20,822 0.1%  EStoxx50 3,304 -0.9%  Nikkei 19,284 -0.5%  EUR 1.0562 -0.4% 
Nasdaq 5,845 0.2%  FTSE100 7,244 -0.4%  Yen 112.1440 0.0%  Oil 56.0 -0.8% 
S&P500 2,367 0.2%  DAX 11,804 -1.2%  GBP 1.2460 0.0%  Gold 1,257 0.6% 

GlaxoSmithKline share [ISIN: GB0009252882]

Realtimequote GlaxoSmithKline plc (GSK) in GBP

Exchange Market
16.42
Last
0
Volume
Time 11:29 AM
02/24/2017 11:29:50 AM UTC-0500
activate push

Stock Price GlaxoSmithKline plc (GSK) in GBP

Activate push
16.40 GBP 0.07 GBP 0.43 %
Trade Time 4:35 PM Trade Date 2/24/2017
Daily High 16.59 Open 16.32
Daily Low 16.19 Prev. Close 16.40
52-week High 17.46 Volume (Qty.) 4,938,627
52-week Low 13.62 Market Cap (USD) 101.80 B
52-week Perf.
Exchange
The price of 16.40 GBP on the exchange London equals a price of 20.43 USD at the current exchange rate for GBP/USD.

Analyst Opinions for GlaxoSmithKline plc (GSK)

More Analyst Opinions
  • All
  • Buy
  • Hold
  • Sell
02/22/17
GlaxoSmithKline Deutsche Bank AG
02/17/17
GlaxoSmithKline Jefferies & Company Inc.
02/15/17
GlaxoSmithKline JP Morgan Chase & Co.
02/15/17
GlaxoSmithKline Goldman Sachs Group Inc.
02/14/17
GlaxoSmithKline UBS AG

Moody's Rating for GlaxoSmithKline plc (GSK)

Investment Grade (High Grade)
Investment Grade (Medium Grade)
Speculative Grade
Rating A2
Rating Update AFF
Date of Rating 5/29/2015
Rating Office Germany

Profile GlaxoSmithKline plc (GSK)

Company Profile
GlaxoSmithKline Plc operates as a science-led global healthcare company that researches and develops a broad range of innovative medicines and brands. It operates in three primary areas of business: Pharmaceuticals, Vaccines and Consumer Healthcare. The Pharmaceuticals business researches, develops and makes available medicines that treat a variety of serious and chronic diseases. The Vaccines business produces pediatric and adult vaccines to prevent a range of infectious diseases including, hepatitis A and B, diphtheria, tetanus and whooping cough, measles, mumps and rubella, polio, typhoid, influenza and bacterial meningitis. The Consumer Healthcare business markets a range of consumer health products based on scientific innovation. The company was founded on December 6, 1999 and is headquartered in Brentford, United Kingdom.
pagehit

Add or Edit Instrument

GlaxoSmithKline Chart - 1 Year - LSE
  • Intraday
  • 1w
  • 3 Mo.
  • 1y
  • 3y
  • 5y
  • Max
  • Exchange: LSE
  • Chart Options

Estimates for GlaxoSmithKline

2016 2017e 2018e
Dividend 0.80 0.80 0.80
Dividend Yield in % 5.10 4.95 4.97
P/E Ratio 15.33 14.50 14.08
EPS 1.02 1.11 1.15

ANALYST DATA FOR GlaxoSmithKline

Sell
Hold
Buy
12
13
14
15
16
17
18
19
20
21


GlaxoSmithKline Key Figures

Market Cap (USD) 101.80 B
Free Float in % 98.87
Number of Shares (Mio.) 4,910.11
Cash Flow per Share 1.22
Book Value per Share 0.23
60-Days Volatility 18.45
P/B Ratio 67.87

Base Data GlaxoSmithKline

Symbol
ISIN GB0009252882
Indices FTSE Allshare, NYSE International 100, STOXX 50, FTSE 100

About the Company GlaxoSmithKline

Country Great Britain

GlaxoSmithKline Historical Prices

02/22/2017
02/22/2017 06:00:00 PM UTC-0500
16.33 5,286,436
02/21/2017
02/21/2017 06:00:00 PM UTC-0500
16.54 6,748,893
02/20/2017
02/20/2017 06:00:00 PM UTC-0500
16.46 6,682,245
02/19/2017
02/19/2017 06:00:00 PM UTC-0500
16.37 4,728,262
02/16/2017
02/16/2017 06:00:00 PM UTC-0500
16.40 9,476,424

GlaxoSmithKline Peer Group

Abbott Laboratories 0.00
0.0%
Alexion Pharmaceuticals 0.00
0.0%
Bayer 0.00
0.0%
Celgene 0.00
0.0%
Gilead Sciences 0.00
0.0%
GlaxoSmithKline 0.00
0.0%
Johnson & Johnson 0.00
0.0%
Merck 0.00
0.0%
Merck 0.00
0.0%
Novartis 0.00
0.0%
Pfizer 0.00
0.0%
Roche 0.00
0.0%
STADA Arzneimittel 0.00
0.0%
Sanofi 0.00
0.0%
Teva Pharmaceutical Industries 0.00
0.0%
Vertex Pharmaceuticals 0.00
0.0%